Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution
Mucormycosis is a devastating invasive fungal disease whose incidence has increased during the past ...
P>We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with ...
We report on an elderly male patient with headache and right-side weakness. Imaging studies revealed...
Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell trans...
Antifungal prophylaxis with posaconazole (POS) has been shown to decrease the mortality associated w...
We describe the clinical courses of 3 patients with hematologic malignancies (2 with acute myelogeno...
Invasive Zygomycetes infection complicating prolonged neutropenia is associated with high mortality ...
Invasive Zygomycetes infection complicating prolonged neutropenia is associated with high mortality ...
Posaconazole is a triazole with broad spectrum of activity against multiple fungi including members ...
Invasive fungal infections are usually associated with immunocompromised states About 40-60% of thes...
Zygomycosis is a frequently lethal invasive infection in high-risk patients such as the immunocompro...
Posaconazole (POS) is approved for prophylaxis o f Asperg i l lus and Candida in fec t ions in immun...
International audienceMucormycosis is a rare, though increasingly prevalent, life-threatening fungal...
A 52-year-old man underwent haematopoietic stem-cell transplant for myelodysplastic syndrome; after ...
We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with ha...
Mucormycosis is a devastating invasive fungal disease whose incidence has increased during the past ...
P>We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with ...
We report on an elderly male patient with headache and right-side weakness. Imaging studies revealed...
Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell trans...
Antifungal prophylaxis with posaconazole (POS) has been shown to decrease the mortality associated w...
We describe the clinical courses of 3 patients with hematologic malignancies (2 with acute myelogeno...
Invasive Zygomycetes infection complicating prolonged neutropenia is associated with high mortality ...
Invasive Zygomycetes infection complicating prolonged neutropenia is associated with high mortality ...
Posaconazole is a triazole with broad spectrum of activity against multiple fungi including members ...
Invasive fungal infections are usually associated with immunocompromised states About 40-60% of thes...
Zygomycosis is a frequently lethal invasive infection in high-risk patients such as the immunocompro...
Posaconazole (POS) is approved for prophylaxis o f Asperg i l lus and Candida in fec t ions in immun...
International audienceMucormycosis is a rare, though increasingly prevalent, life-threatening fungal...
A 52-year-old man underwent haematopoietic stem-cell transplant for myelodysplastic syndrome; after ...
We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with ha...
Mucormycosis is a devastating invasive fungal disease whose incidence has increased during the past ...
P>We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with ...
We report on an elderly male patient with headache and right-side weakness. Imaging studies revealed...